Loading organizations...
Knott Partners operates as a value-focused hedge fund, headquartered in Syosset, New York. The firm specializes in managing investment vehicles, typically limited partnerships, that pursue strategies to identify and capitalize on undervalued assets across various markets. Through diligent research and a disciplined approach, Knott Partners aims to generate long-term returns for its investors.
The firm was established in 1987 by David M. Knott, a Wharton alumnus, who conceived of a dedicated fund centered on value investing principles. Knott, who later retired as its founder and managing partner, steered the firm from its inception with a clear vision for its investment philosophy. His background informed the strategic direction and operational integrity of the organization.
Knott Partners primarily serves institutional and accredited individual investors who seek exposure to actively managed, value-oriented investment strategies. The firm's long-term vision is to consistently apply its core investment tenets to navigate market opportunities and preserve capital, focusing on fundamental analysis to guide its portfolio construction and management decisions.
Knott Partners has 1 tracked investment across 1 company. The latest tracked deal is $42.8M Series D in ILiAD Biotechnologies in September 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 6, 2022 | ILiAD Biotechnologies | $42.8M Series D | Knott Partners | — |